The Healthcare Businesswomen’s Association (HBA), a global not-for-profit organization dedicated to furthering the advancement and impact of women in the business of healthcare, points to a paper recently published by McKinsey, it’s annual Women in the Workplace study. Data from the study looks deeper into how women fare on compensation, promotion rates, and positions compared to peers in other industry segments.
Overall, the news is favorable for women in the business of healthcare-including those working in pharma, medical devices, and biotech.
Key takeaways from the McKinsey report include:
You can read the full Women in the Healthcare Industry report here.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.